These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 4847248)

  • 1. Studies on the in vivo effects of antibody. Interaction of IgM antibody and complement in the immune clearance and destruction of erythrocytes in man.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Aug; 54(2):339-48. PubMed ID: 4847248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of complement in the clearance of cold agglutinin-sensitized erythrocytes in man.
    Jaffe CJ; Atkinson JP; Frank MM
    J Clin Invest; 1976 Oct; 58(4):942-9. PubMed ID: 965497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of human erythrocyte membrane properties by complement fixation.
    Durocher JR; Gockerman JP; Conrad ME
    J Clin Invest; 1975 Apr; 55(4):675-80. PubMed ID: 1120777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of antibody and complement in the immune clearance and destruction of erythrocytes. I. In vivo effects of IgG and IgM complement-fixing sites.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):575-82. PubMed ID: 4536807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Bacillus Calmette-Guerin-induced macrophage activation on the in vivo clearance of sensitized erythrocytes.
    Atkinson JP; Frank MM
    J Clin Invest; 1974 Jun; 53(6):1742-9. PubMed ID: 4598114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of macrophage C3b receptor function by cytochalasin-sensitive structures.
    Atkinson JP; Michael JM; Chaplin H; Parker CW
    J Immunol; 1977 Apr; 118(4):1292-9. PubMed ID: 557509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.
    Beebe DP; Cooper NR
    J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-binding sites on C3 and C3b.
    Dierich MP; Bokisch VA
    J Immunol; 1977 Jun; 118(6):2145-50. PubMed ID: 864256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated guinea-pig C3 and the immune adherence receptor (a complement receptor) on cell membranes.
    Okada H; Okada N
    Immunology; 1975 Jun; 28(6):1165-71. PubMed ID: 1169221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenoantiserum to human C3 receptors: its preparation and effect on the C3b and C3d receptors of tonsil cells and the C3b receptors of erythrocytes and neutrophils.
    Gerdes J; Klatt U; Stein H
    Immunology; 1980 Jan; 39(1):75-84. PubMed ID: 6991397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.
    Schifferli JA; Ng YC; Paccaud JP; Walport MJ
    Clin Exp Immunol; 1989 Mar; 75(3):329-35. PubMed ID: 2522842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes.
    Atkinson JP; Schreiber AD; Frank MM
    J Clin Invest; 1973 Jun; 52(6):1509-17. PubMed ID: 4703235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quantitative relationship between clearance rate constants and number of C1-fixing sites.
    Meryhew NL; Marsden K; Runquist OA
    J Immunol; 1982 Sep; 129(3):1147-52. PubMed ID: 7108203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
    Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of in vivo immune complex formation and clearance in man.
    Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
    J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lymphocytes bear membrane receptors for C3b and C3d.
    Eden A; Miller GW; Nussenzweig V
    J Clin Invest; 1973 Dec; 52(12):3239-42. PubMed ID: 4543024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.